A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial

Xinxing Lai, Zhenghao Fang, Zhenyu Dong, Shengxian Wu, Xiao‐Hua Zhou, Ying GaoClinical 2023 · DOI

Abstract

The current comparison demonstrated that SXC monotherapy is at least as effective in real-world settings as within the randomized controlled trial for BP lowering in patients with grade 1 hypertension.
BibTeX
@inproceedings{lai2023propensity,
  author = {Xinxing Lai and Zhenghao Fang and Zhenyu Dong and Shengxian Wu and Xiao‐Hua Zhou and Ying Gao},
  title = {{A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.1080/10641963.2023.2249269},
}

Loading related content...

Figure